About Aigen Therapeutics Private Limited
Data last updated: 23 February 2026
Aigen Therapeutics Private Limited is a private limited company based in Gurgaon, Haryana, India, recognised as a startup by DPIIT. It specialises in biotechnology, a part of the broader life sciences sector. Incorporated on 08 May 2019, the company has been in operation for over 7 years.
Registered with ROC Haryana under CIN U74994HR2019PTC080219.
Capital: an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Anup Kumar Gupta and Yash Pal Chaddah.
Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: 84 Sector 9A, Gurgaon, Haryana, India – 122001.
The company is associated with 1 brand - Aigen Therapeutics.
For more details, the company can be reached via its website aigenthera.com.
-
EmailLocked
-
TelephoneLocked
-
Website
-
Social MediaLocked
-
Registered Address84 Sector 9A, Gurgaon, Haryana, India – 122001
-
IndustryLife Sciences, Biotechnology
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Associated Brands with Aigen Therapeutics Private Limited
Aigen Therapeutics Private Limited operates one associated brand: AIGen Therapeutics. These brands represent Aigen Therapeutics Private Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| AI-driven company developing therapies for genetic and infectious diseases using advanced algorithms. | aigenthera.com |
Competitors & Alternatives of Aigen Therapeutics Private Limited
Brands and companies operating in the same space as Aigen Therapeutics Private Limited include Spark Therapeutics, BridgeBio, Forge Biologics and 6 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
Spark Therapeutics
|
Gene therapies for rare diseases including retinal dystrophies are developed. | Philadelphia, United States, United States | 2013 |
BridgeBio
|
Therapeutics for genetic diseases are developed through targeted interventions. | Palo Alto, United States, United States | 2015 |
Forge Biologics
|
Gene therapies for rare diseases are developed to treat patients. | Columbus, United States, United States | 2020 |
Insitro
|
An AI-enabled platform is developed for infectious disease treatment. | San Francisco, United States, United States | 2018 |
Alnylam
|
RNA interference-based therapeutics are developed for multiple disorders. | Cambridge, United States, United States | 2002 |
Avidity Biosciences
|
Antibody-siRNA complexes are developed for cancer treatment. | San Diego, United States, United States | 2012 |
Ultragenyx
|
Therapeutics for rare and ultra-rare metabolic diseases are developed. | Novato, United States, United States | 2010 |
Chimerix
|
Antiviral oral therapeutics are developed for infectious diseases and cancers. | Durham, United Kingdom, United Kingdom | 2002 |
ATAI
|
A biopharmaceutical company accelerating innovative mental health treatments. | Munich, Germany, Germany | 2018 |
Board of Directors of Aigen Therapeutics Private Limited
Aigen Therapeutics Private Limited is currently managed by 2 directors, with 1 former director having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anup Kumar Gupta | Director | 08 May 2019 | 7 Years 3 Months | Current |
| Yash Pal Chaddah | Director | 08 May 2019 | 7 Years 3 Months | Current |
Financials of Aigen Therapeutics Private Limited FY 2025 filings available
Ten-year financial statements for Aigen Therapeutics Private Limited
Historical statement values and trend charts require an active report plan.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Aigen Therapeutics Private Limited
Shareholding and ownership data for Aigen Therapeutics Private Limited
Promoter, institutional, public, and beneficial ownership values require an active report plan.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings Aigen Therapeutics Private Limited
Aigen Therapeutics Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Aigen Therapeutics Private Limited
View historical data on people associated with Aigen Therapeutics Private Limited, including employment history and EPFO contributions.
Employee and EPFO history for Aigen Therapeutics Private Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Aigen Therapeutics Private Limited
GST registrations and filing compliance for Aigen Therapeutics Private Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Aigen Therapeutics Private Limited
Credit ratings, litigation, and regulatory alerts for Aigen Therapeutics Private Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Aigen Therapeutics Private Limited
MSME payment history for Aigen Therapeutics Private Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Aigen Therapeutics Private Limited
Corporate group structure for Aigen Therapeutics Private Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Aigen Therapeutics Private Limited
MCA filings and documents for Aigen Therapeutics Private Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Aigen Therapeutics Private Limited
Frequently Asked Questions about Aigen Therapeutics Private Limited
Aigen Therapeutics Private Limited is an active private limited company in the life sciences sector based in Gurgaon, Haryana, India. It was incorporated on 08 May 2019 (7+ years old) and is registered under CIN U74994HR2019PTC080219.
The current directors of Aigen Therapeutics Private Limited are:
- Anup Kumar Gupta - Director
- Yash Pal Chaddah - Director
The primary industry of Aigen Therapeutics Private Limited is life sciences. The company specifically operates in biotechnology. The company is currently active in this sector.
Yes, Aigen Therapeutics Private Limited is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Aigen Therapeutics Private Limited can be reached at the registered office: 84 Sector 9A, Gurgaon, Haryana, India – 122001, or through the website aigenthera.com.
The authorised capital is ₹5 Lakh, and the paid-up capital is ₹1 Lakh.